Harada N, Omura T
J Biochem. 1983 May;93(5):1361-73. doi: 10.1093/oxfordjournals.jbchem.a134271.
The syntheses of two different molecular species of cytochrome P-450, P-450(PB), and P-450(MC), were examined using normal and drug-treated rats, and the rate of synthesis was correlated with the drug-induced increase of the amounts in the liver microsomes of treated animals. Phenobarbital (PB) and 3-methylcholanthrene (MC) were used as inducers. The syntheses of cytochrome b5 and NADPH-cytochrome P-450 reductase (fpT) were also examined. In vivo incorporation of L-[3H]leucine indicated a large increase of P-450(PB) synthesis in the livers of PB-treated animals, which reached a plateau value about 18-fold higher than the control level at 12 h. The synthesis of fpT was also stimulated by PB showing a peak value of 3 times the control at 12 h after PB administration, but it returned to the control level afterwards. On the other hand, the syntheses of P-450(MC) and cytochrome b5 did not change at all. Similarly, MC administration selectively induced the synthesis of P-450(MC), which was about 24 times the control at 6 h, whereas those of P-450(PB), cytochrome b5, and fpT were not affected by MC. Analysis of nascent peptides and in vitro translation of polysomes and total liver RNA prepared from control and drug-treated animals were also carried out, and the results of these in vitro experiments confirmed the observations in in vivo incorporation studies. It was found that both free and membrane-bound ribosomes participate in the syntheses of P-450(PB) and P-450(MC) in the case of control animals. PB and MC induced the syntheses of P-450(PB) and P-450(MC) by bound ribosomes but not by free ribosomes, and the contribution of bound ribosomes to the syntheses of these two species of cytochrome P-450 was predominant in the case of drug-treated animals. The molecular sizes of in vitro synthesized P-450(PB) and P-450(MC) were the same as those of authentic samples prepared from liver microsomes.
利用正常大鼠和经药物处理的大鼠,研究了两种不同分子形式的细胞色素P - 450,即P - 450(PB)和P - 450(MC)的合成情况,并将合成速率与药物诱导处理动物肝脏微粒体中含量的增加相关联。使用苯巴比妥(PB)和3 - 甲基胆蒽(MC)作为诱导剂。还研究了细胞色素b5和NADPH - 细胞色素P - 450还原酶(fpT)的合成情况。体内掺入L - [3H]亮氨酸表明,经PB处理的动物肝脏中P - 450(PB)的合成大幅增加,在12小时时达到比对照水平高约18倍的平台值。fpT的合成也受到PB的刺激,在给予PB后12小时达到对照值的3倍峰值,但随后又恢复到对照水平。另一方面,P - 450(MC)和细胞色素b5的合成完全没有变化。同样,给予MC选择性地诱导了P - 450(MC)的合成,在6小时时约为对照值的24倍,而P - 450(PB)、细胞色素b5和fpT的合成不受MC影响。还对来自对照和经药物处理动物的新生肽进行了分析以及对多核糖体和肝脏总RNA进行了体外翻译,这些体外实验的结果证实了体内掺入研究中的观察结果。发现在对照动物中,游离核糖体和膜结合核糖体都参与了P - 450(PB)和P - 450(MC)的合成。PB和MC通过结合核糖体而非游离核糖体诱导P - 450(PB)和P - 450(MC)的合成,并且在经药物处理的动物中,结合核糖体对这两种细胞色素P - 450合成的贡献占主导地位。体外合成的P - 450(PB)和P - 450(MC)的分子大小与从肝脏微粒体制备的真实样品相同。